IRIS
IANNONE, Florenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.126
EU - Europa 3.193
AS - Asia 1.611
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 10
SA - Sud America 10
AF - Africa 2
Totale 20.967
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.112
CN - Cina 1.022
SE - Svezia 976
FR - Francia 671
IT - Italia 554
SG - Singapore 432
DE - Germania 261
GB - Regno Unito 218
FI - Finlandia 199
UA - Ucraina 135
BE - Belgio 59
VN - Vietnam 53
IE - Irlanda 43
IN - India 36
CZ - Repubblica Ceca 19
IR - Iran 18
TR - Turchia 17
EU - Europa 15
CA - Canada 10
ES - Italia 10
AT - Austria 7
AU - Australia 7
JP - Giappone 6
NL - Olanda 6
BR - Brasile 5
HK - Hong Kong 5
HR - Croazia 5
ID - Indonesia 5
CH - Svizzera 3
RO - Romania 3
RU - Federazione Russa 3
TH - Thailandia 3
AM - Armenia 2
CL - Cile 2
EE - Estonia 2
GR - Grecia 2
HU - Ungheria 2
LU - Lussemburgo 2
MN - Mongolia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
SA - Arabia Saudita 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
BW - Botswana 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GF - Guiana Francese 1
IS - Islanda 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MP - Marianne Settentrionali, isole 1
MX - Messico 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 20.967
Salva come PNG Salva come JPEG
Città #
Fairfield 2.589
Woodbridge 1.845
Houston 1.392
Chandler 1.368
Ashburn 1.168
Seattle 1.065
Cambridge 934
Ann Arbor 922
Wilmington 808
Nyköping 800
Jacksonville 431
Lawrence 324
Roxbury 311
Singapore 307
Nanjing 256
Beijing 243
Des Moines 201
Bari 184
Princeton 175
Inglewood 172
New York 167
San Diego 114
Boardman 85
Dearborn 80
Shenyang 73
Santa Clara 70
Paris 61
Brussels 59
Hebei 59
London 59
Dong Ket 52
Jiaxing 52
Nanchang 51
Dublin 43
Munich 41
Los Angeles 40
Tianjin 37
Brooklyn 36
Changsha 35
Redwood City 31
Pune 24
Guangzhou 22
Falls Church 19
Helsinki 19
Shanghai 18
Jinan 16
San Francisco 15
San Mateo 15
Milan 14
Norwalk 14
Prescot 13
Ardabil 12
Augusta 12
Chicago 12
Hounslow 12
Washington 12
Zhengzhou 12
Brno 11
Indiana 11
Durham 10
Hefei 10
Kilburn 10
Giovinazzo 9
Wuhan 9
Gallarate 8
Leawood 8
Monmouth Junction 8
Islington 7
Rome 7
Toronto 7
Triggiano 7
Vienna 7
Acton 6
Ankara 6
Brindisi 6
Edinburgh 6
Hangzhou 6
Kunming 6
Taizhou 6
Tappahannock 6
Taranto 6
Bursa 5
Chiswick 5
Clifton 5
Modugno 5
Naples 5
Ningbo 5
Olomouc 5
Pamplona 5
Trani 5
Cerignola 4
Florence 4
Frankfurt am Main 4
Fuzhou 4
Mola Di Bari 4
New Bedfont 4
Padova 4
Verona 4
Zagreb 4
Boston 3
Totale 17.268
Salva come PNG Salva come JPEG
Nome #
Safety of Long-Term Biologic Therapy in Rheumatologic Patients With a Previously Resolved Hepatitis B Viral Infection 138
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 138
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study 131
A rare association of anti-alanine-transfer RNA synthetase (anti-PL12) syndrome and sporadic inclusion body myositis 127
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 124
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 121
Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients 121
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study 119
No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan 118
Digital ulcers predict a worse disease course in patients with systemic sclerosis 118
Basic characteristics of adults with periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome in comparison with the typical pediatric expression of disease 117
Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis 113
Autophagy markers LC3 and p62 accumulate in immune‐mediated necrotizing myopathy 113
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register 111
Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA 109
Retinal vessels thrombosis as onset manifestation of systemic sclerosis: 3 clinical cases 109
Leucocytoclastic vasculitis as onset symptom of ulcerative colitis 108
Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy 108
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 108
Refractory knee giant cell tumor of the synovial membrane treated with intra-articular injection of Infliximab: A case series and review of the literature 107
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 107
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 107
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 106
Evaluation of differences in carotid intima-media thickness in patients affected by systemic rheumatic diseases 105
Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies 105
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 104
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis 104
Update on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy features 104
Different switching rate of anti-TNF-α drugs in monotherapy and in combination with methotrexate in a cohort of rheumatoid arthritis patients in the real life 103
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: Premises, perils, and perspectives 103
Management of Small Vessel Vasculitides 102
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives 102
A Case of Osteonecrosis of the Jaw in a Patient with Crohn's Disease Treated with Infliximab 102
null 101
ASSOCIATION OF SYSTEMIC SCLEROSIS AND PSORIATIC ARTHRITIS: A CASE REPORT 100
PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists 100
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 99
A false occult hepatitis B virus infection developed in a patient with psoriatic arthritis under infliximab and methotrexate therapy 99
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 99
Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate 98
Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice 98
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: Results from a collaborative project of 11 European biologic registers 98
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 98
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: Data from GISEA, the Italian biologics register 97
Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: A multicenter randomized clinical trial 97
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 97
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study. 96
Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab 96
Orofacial Manifestations and Temporomandibular Disorders of Sjogren Syndrome: An Observational Study 96
Lipid Profile of Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Drugs Changes According to Disease Activity and Predicts Clinical Response 95
Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study 95
Serum amyloid-A in Behçet's disease 94
Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa 94
Digital laser doppler flowmetry may discriminate "limited" from "diffuse" systemic sclerosis 93
Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature 93
Early clinical response predicts low disease activity at one year in rheumatoid arthritis patients on treatment with certolizumab in real-life settings. An appraisal of the Italian registry GISEA 93
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 93
Untangling the web of systemic autoinflammatory diseases 92
Effects and safety of rituximab in systemic sclerosis: An analysis from the European Scleroderma Trial and Research (EUSTAR) group 92
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 91
AN UNWELCOME HOST IN THE PATHOGENESIS OF ARTHRITIDES 90
Obesity and Inflammation – Targets for OA Therapy 90
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 90
null 90
The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts 90
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 90
AB0618 A unique ultrasound pattern of adipose tissue in systemic sclerosis patients: a comparison with rheumatoid arthritis patients and healthy controls. two sides of adipose tissue involvement in systemic chronic inflammatory diseases 90
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 89
ANTI-TNFA THERAPY IN PSORIATIC ARTHRITIS: DIFFERENT RATE OF REMISSION IN POLYARTICULAR AND OLIGOARTICULAR SUBSETS 89
Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register) 88
The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries 88
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives 88
Sarcoidosis presenting with Raynaud's syndrome: a case report 87
Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: International recommendations 87
Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art 87
null 86
null 86
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 86
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 86
Isolated thrombocytopenia associated with low dose methotrexate therapy 85
PHENOTYPING OF CHONDROCYTES FROM HUMAN OSTEOARTHRITIC CARTILAGE: CHONDROCYTE EXPRESSION OF BETA INTEGRINS AND CORRELATION WITH ANATOMIC INJURY 85
null 85
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 85
Clinical spectrum time course in anti jo-1 positive antisynthetase syndrome: Results from an international retrospective multicenter study 85
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 85
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 85
null 84
Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab 84
Prevalence of anti-CCP antibodies in systemic sclerosis 84
null 84
Peripheral and central nervous system correlates in fibromyalgia 84
Update on the profile of the EUSTAR cohort: An analysis of the EULAR Scleroderma Trials and Research group database 83
null 83
Generation of a core set of items to develop classification criteria for Scleroderma renal crisis using consensus methodology 82
null 82
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 82
null 82
null 81
HBV reactivation in patients treated with antitumor necrosis factor-alpha (TNF- α) agents for rheumatic and dermatologic conditions: A systematic review and meta-analysis 81
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 81
Totale 9.735
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.426
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.990 0 0 0 464 727 603 650 693 779 399 455 220
2020/20213.462 213 317 250 149 582 251 288 293 326 367 212 214
2021/20222.494 191 220 41 125 109 185 163 146 153 171 344 646
2022/20233.726 576 439 289 302 367 496 78 434 546 28 109 62
2023/20241.252 105 260 59 98 105 268 38 60 15 46 33 165
2024/2025748 146 93 484 25 0 0 0 0 0 0 0 0
Totale 22.247